Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-5 of 5 for Blood transfusion

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. A Study to Evaluate Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT)

    Rochester, MN

  3. A Study to Evaluate Tranexamic Acid (TXA) Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection

    Rochester, MN

  4. Myocardial Ischemia and Transfusion

    Rochester, MN

  5. Laboratory Assay Optimization 2.0

    Rochester, MN


Mayo Clinic Footer